DIFFERENCES IN RESPONSIVENESS TO CD3 STIMULATION BETWEEN NAIVE AND MEMORY CD4+ T-CELLS CANNOT BE OVERCOME BY CD28 COSTIMULATION

被引:35
作者
KUIPER, H
BROUWER, M
DEBOER, M
PARREN, P
VANLIER, RAW
机构
[1] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,DEPT CLIN VIROIMMUNOL,1066 CX AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,EXPTL & CLIN IMMUNOL LAB,AMSTERDAM,NETHERLANDS
[3] INNOGENET,GHENT,BELGIUM
关键词
CD28; B7; CD4(+)CD45RA(+) CELLS; CD4(+)CD45RO(+) CELLS; T CELL ACTIVATION;
D O I
10.1002/eji.1830240903
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation of naive CD4(+) T cells is essential for the induction of primary immune responses. However, this subset is less responsive to signaling via T cell receptor/CD3 (TcR/CD3) complex than memory CD4(+) cells. For mitogenic activation of T cells, in addition to triggering of the TcR/CD3 complex, costimulatory signals are required that can be generated by surface structures present on the antigen-presenting cells. We investigated here whether differences in responsiveness to TcR/CD3 stimulation of naive and memory cells can be overcome by the costimulatory pathway B7/CD28. Using a B7-dependent system we show that even in the presence of optimal CD28 costimulation, CD4(+) naive cells still have more stringent TcR/CD3 activation requirements than memory cells. Furthermore, titration of the B7 signal revealed that for activation of naive CD4(+) cells a higher level of cross-linking of CD28 molecules is required than for memory cells. Thus, our results show that at least two signals are required for activation of both CD4(+) memory and naive cells, but that for activation of naive cells higher cross-linking of both CD3 and CD28 molecules is necessary.
引用
收藏
页码:1956 / 1960
页数:5
相关论文
共 35 条
[1]   FUNCTIONAL EXPRESSION OF B7/BB1 ON ACTIVATED LYMPHOCYTES-T [J].
AZUMA, M ;
YSSEL, H ;
PHILLIPS, JH ;
SPITS, H ;
LANIER, LL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :845-850
[2]  
BYRNE JA, 1988, J IMMUNOL, V141, P3249
[3]  
CROFT M, 1992, J EXP MED, V1431, P1437
[4]  
DAMLE NK, 1992, J IMMUNOL, V148, P1985
[5]   FUNCTIONAL-CHARACTERIZATION OF A NOVEL ANTI-B7 MONOCLONAL-ANTIBODY [J].
DEBOER, M ;
PARREN, P ;
DOVE, J ;
OSSENDORP, F ;
VANDERHORST, G ;
REEDER, J .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (12) :3071-3075
[6]  
DEJONG R, 1991, J IMMUNOL, V146, P2088
[7]  
FREEDMAN AS, 1987, J IMMUNOL, V139, P3260
[8]   SELECTIVE INDUCTION OF B7/BB-1 ON INTERFERON-GAMMA STIMULATED MONOCYTES - A POTENTIAL MECHANISM FOR AMPLIFICATION OF T-CELL ACTIVATION THROUGH THE CD28 PATHWAY [J].
FREEDMAN, AS ;
FREEMAN, GJ ;
RHYNHART, K ;
NADLER, LM .
CELLULAR IMMUNOLOGY, 1991, 137 (02) :429-437
[9]   CLONING OF B7-2 - A CTLA-4 COUNTER-RECEPTOR THAT COSTIMULATES HUMAN T-CELL PROLIFERATION [J].
FREEMAN, GJ ;
GRIBBEN, JG ;
BOUSSIOTIS, VA ;
NG, JW ;
RESTIVO, VA ;
LOMBARD, LA ;
GRAY, GS ;
NADLER, LM .
SCIENCE, 1993, 262 (5135) :909-911
[10]  
FREEMAN GJ, 1992, J IMMUNOL, V149, P3795